Phase II trial of liposomal doxorubicin (Doxil) in advanced soft tissue sarcomas.
Chidiac T, Budd GT, Pelley R, Sandstrom K, McLain D, Elson P, Crownover R, Marks K, Muschler G, Joyce M, Zehr R, Bukowski R.
Chidiac T, et al.
Invest New Drugs. 2000 Aug;18(3):253-9. doi: 10.1023/a:1006429907449.
Invest New Drugs. 2000.
PMID: 10958594
Clinical Trial.